Pfizer and Allergan have
confirmed that they are in
“preliminary friendly discussions”
about a possible merger.
They’re not commenting further,
and have cautioned that no
agreement has been reached and
there is no certainty that the talks
will lead to a deal being finalised.
Allergan was acquired earlier
this year by Actavis for more than
US$70 billion, with the combined
business subsequently taking on
the Allergan name.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Oct 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Oct 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.